The FDA declared the Zepbound shortage over—and it's rattling the weight-loss industry
qz.com › fda-zepbound-weight-loss-hims-hers-noom-1851725254
This story seems to be about:
This story seems to be about:
The U.S. Food and Drug Administration announced Thursday that the shortage of tirzepatide—the active ingredient in Eli Lilly’s (LLY) popular diabetes and weight-loss drugs Mounjaro and Zepbound—is officially over.